Tim Hui-Ming Huang, Ph.D., who became CTRC’s deputy director on Oct. 1, also is chair of the Department of Molecular Medicine at the Institute of Biotechnology. He will lead translational and basic science research programs at the CTRC.

CTRC Deputy Director
Tim Hui-Ming Huang, Ph.D., began his new role on Oct. 1 as deputy director of the Cancer Therapy and Research Center (CTRC) and chair of the Department of Molecular Medicine at the Institute of Biotechnology. He was recruited from Ohio State University, where he served as professor of human cancer genetics in the Department of Molecular Virology, Immunology and Medical Genetics.

Dr. Huang will lead translational and basic science research programs at the CTRC. In addition, he and his lab team will focus on developing new technology toward early detection of cancer and to further developing “cocktail approaches” (using appropriate combinations of therapies) to treat cancer.